January 20th, 2012

Mayo CEO defends use of proton beam therapy

By

 An op-ed article from the Jan. 3 New York Times questions the motives and consequences of Mayo Clinic's decision to open two proton beam therapy facilities for the advanced treatment of certain cancers. In a piece titled "It Costs More, But Is It Worth More?" ("How Mayo drives up the cost of health care," on Startribune.com www.startribune.com/opinion/otherviews/136597788.html), the authors suggest that proton beam therapy is of unproven value and that the programs were initiated to generate revenue. Mayo Clinic takes serious issue with the authors' use of Mayo Clinic and its programs in this manner. As a not-for-profit institution, we are motivated by the best interests of our patients, not "profit" or competitiveness. Additional coverage: Oregon Live

Star Tribune, by John Noseworthy, 1/5/2012

Tags: Cancer, Mayo Clinic Arizona, Mayo Clinic Rochester

Contact Us · Privacy Policy